BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 25168749)

  • 1. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.
    Cui B; Feng Q; Wang H; Wang M; Peng Z; Li P; Huang G; Liu Z; Wu P; Fan Z; Ji G; Wang X; Wu K; Fan D; Zhang F
    J Gastroenterol Hepatol; 2015 Jan; 30(1):51-8. PubMed ID: 25168749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease.
    Zhang FM; Wang HG; Wang M; Cui BT; Fan ZN; Ji GZ
    World J Gastroenterol; 2013 Nov; 19(41):7213-6. PubMed ID: 24222969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
    Suskind DL; Brittnacher MJ; Wahbeh G; Shaffer ML; Hayden HS; Qin X; Singh N; Damman CJ; Hager KR; Nielson H; Miller SI
    Inflamm Bowel Dis; 2015 Mar; 21(3):556-63. PubMed ID: 25647155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile.
    Kao D; Hotte N; Gillevet P; Madsen K
    J Clin Gastroenterol; 2014 Aug; 48(7):625-8. PubMed ID: 24667590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study.
    Wang H; Cui B; Li Q; Ding X; Li P; Zhang T; Yang X; Ji G; Zhang F
    Adv Ther; 2018 Nov; 35(11):1935-1944. PubMed ID: 30328062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease.
    Li P; Zhang T; Xiao Y; Tian L; Cui B; Ji G; Liu YY; Zhang F
    Appl Microbiol Biotechnol; 2019 Jan; 103(1):349-360. PubMed ID: 30357440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
    Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
    Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
    Kong L; Lloyd-Price J; Vatanen T; Seksik P; Beaugerie L; Simon T; Vlamakis H; Sokol H; Xavier RJ
    Gastroenterology; 2020 Dec; 159(6):2193-2202.e5. PubMed ID: 32860788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study.
    Sokol H; Landman C; Seksik P; Berard L; Montil M; Nion-Larmurier I; Bourrier A; Le Gall G; Lalande V; De Rougemont A; Kirchgesner J; Daguenel A; Cachanado M; Rousseau A; Drouet É; Rosenzwajg M; Hagege H; Dray X; Klatzman D; Marteau P; ; Beaugerie L; Simon T
    Microbiome; 2020 Feb; 8(1):12. PubMed ID: 32014035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseases.
    Zou M; Jie Z; Cui B; Wang H; Feng Q; Zou Y; Zhang X; Yang H; Wang J; Zhang F; Jia H
    FEBS Open Bio; 2020 Jan; 10(1):41-55. PubMed ID: 31622538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.
    Yang Z; Bu C; Yuan W; Shen Z; Quan Y; Wu S; Zhu C; Wang X
    Dig Dis Sci; 2020 Jan; 65(1):150-157. PubMed ID: 31367877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.
    Karolewska-Bochenek K; Grzesiowski P; Banaszkiewicz A; Gawronska A; Kotowska M; Dziekiewicz M; Albrecht P; Radzikowski A; Lazowska-Przeorek I
    Adv Exp Med Biol; 2018; 1047():81-87. PubMed ID: 29151253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease.
    Vaughn BP; Vatanen T; Allegretti JR; Bai A; Xavier RJ; Korzenik J; Gevers D; Ting A; Robson SC; Moss AC
    Inflamm Bowel Dis; 2016 Sep; 22(9):2182-90. PubMed ID: 27542133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis.
    Cui B; Li P; Xu L; Zhao Y; Wang H; Peng Z; Xu H; Xiang J; He Z; Zhang T; Nie Y; Wu K; Fan D; Ji G; Zhang F
    J Transl Med; 2015 Sep; 13():298. PubMed ID: 26363929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.
    Angelberger S; Reinisch W; Makristathis A; Lichtenberger C; Dejaco C; Papay P; Novacek G; Trauner M; Loy A; Berry D
    Am J Gastroenterol; 2013 Oct; 108(10):1620-30. PubMed ID: 24060759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease: The first report.
    He Z; Cui BT; Zhang T; Li P; Long CY; Ji GZ; Zhang FM
    World J Gastroenterol; 2017 May; 23(19):3565-3568. PubMed ID: 28596693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.
    Youngster I; Russell GH; Pindar C; Ziv-Baran T; Sauk J; Hohmann EL
    JAMA; 2014 Nov; 312(17):1772-8. PubMed ID: 25322359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation for Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Wei W; Li Z
    Tech Coloproctol; 2021 May; 25(5):495-504. PubMed ID: 33759066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile.
    Gutin L; Piceno Y; Fadrosh D; Lynch K; Zydek M; Kassam Z; LaMere B; Terdiman J; Ma A; Somsouk M; Lynch S; El-Nachef N
    United European Gastroenterol J; 2019 Jul; 7(6):807-814. PubMed ID: 31316785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
    Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.